Praxis Precision Shares Rally On Price Target Hikes: Analyst Sees Upside As High As 100% For Stock
Praxis Precision Medicines (PRAX) shares rallied after analysts increased their price targets following the company's FDA submissions for two experimental drugs, ulixacaltamide and relutrigine, both of which have Breakthrough Therapy Designation. Truist raised its price target to $700, citing the completed NDA submissions as "notable," while Wells Fargo expressed surprise that priority review wasn't requested for Ulixadolid despite its breakthrough status. Wedbush also increased its price target but maintained an 'Underperform' rating, holding reservations on the ulixacaltamide filing.
Truist reiterates Buy on Amer Sports stock citing brand momentum By Investing.com
Truist Securities has reiterated a Buy rating on Amer Sports Inc. (NYSE:AS), setting a $46.00 price target. The firm cites strong brand momentum for Arc’teryx and Salomon, particularly due to their viral success on social media platforms like TikTok and Pinterest, and believes the brands are poised for significant U.S. expansion. Analysts are generally optimistic about Amer Sports' growth prospects, further supported by the company's recent announcement to redeem $80 million in senior secured notes.
PayPal Holdings, Inc. $PYPL Shares Purchased by Jupiter Asset Management Ltd.
Jupiter Asset Management Ltd. significantly increased its stake in PayPal Holdings, Inc. during the third quarter, purchasing an additional 576,228 shares. This institutional accumulation comes despite recent insider selling, a CEO transition, and multiple class-action lawsuits against PayPal. Analysts have also lowered price targets for PayPal, which is currently trading near its 52-week low, after the company missed its Q4 EPS estimates.
Analysts Are Bullish on These Industrial Goods Stocks: Fluor (FLR), Clean Harbors (CLH)
Two industrial goods stocks, Fluor (FLR) and Clean Harbors (CLH), have received bullish ratings from analysts. Truist Financial reiterated a Buy rating for Fluor with a $59.00 price target, while also maintaining a Buy rating on Clean Harbors with a $310.00 price target. Both companies hold a Moderate Buy analyst consensus rating, indicating positive sentiment from the Street.
King Luther Capital Management Corp Acquires 115,809 Shares of Truist Financial Corporation $TFC
King Luther Capital Management Corp significantly increased its stake in Truist Financial Corporation (NYSE:TFC) by 94.2% in the third quarter, acquiring an additional 115,809 shares. This makes their total holdings 238,788 shares valued at $10.92 million. Concurrently, other hedge funds also adjusted their positions, and Truist Financial has seen insider selling from its CFO and a director, while analysts have issued a mix of "Buy" and "Hold" ratings with an average target price of $56.47.
Truist Trims Price Target on Texas Roadhouse to $186 From $188, Keeps Hold Rating
Truist has lowered its price target for Texas Roadhouse (TXRH) to $186 from $188, while maintaining a Hold rating on the stock. This adjustment follows previous reports of the company's Q4 earnings and other analyst actions, including a recent downgrade by Truist. Texas Roadhouse is a restaurant company operating three main concepts: Texas Roadhouse, Bubba’s 33, and Jaggers.
Compass Wealth Management LLC Invests $2.04 Million in Regeneron Pharmaceuticals, Inc. $REGN
Compass Wealth Management LLC has acquired a new stake of 3,634 shares, valued at $2.04 million, in Regeneron Pharmaceuticals (NASDAQ:REGN) during the third quarter. Other institutional investors have also significantly increased their holdings in the biopharmaceutical company. Analysts currently have an average rating of "Moderate Buy" for REGN with a consensus target price of $793.81.
Wells Fargo Downgrades Molina Healthcare to Equalweight From Overweight, Adjusts PT to $141 From $208
Wells Fargo has downgraded Molina Healthcare (MOH) from "Overweight" to "Equalweight" and reduced its price target from $208 to $141. This adjustment reflects a more cautious outlook on the healthcare provider's stock. The article also lists several other recent analyst adjustments to Molina Healthcare's price target and ratings.
CenterBook Partners LP Invests $1.61 Million in Sysco Corporation $SYY
CenterBook Partners LP has acquired a new stake of 19,600 shares in Sysco Corporation (NYSE:SYY), valued at approximately $1.61 million. This investment comes as several other institutional investors have also adjusted their holdings in Sysco. Analysts currently rate Sysco as a "Moderate Buy" with a consensus target price of $90.31, despite recent insider stock sales.
Analog Devices to Participate in the Morgan Stanley Technology, Media, and Telecom Conference
Analog Devices, Inc. announced that CFO Richard Puccio will present at the Morgan Stanley Technology, Media, and Telecom Conference in San Francisco on March 3, 2026. The presentation will cover business topics and trends, with a live webcast and 30-day archive available on the company's investor relations website.
Wall Street Bullish on Huntington Bancshares (HBAN), Here’s Why
Wall Street analysts hold a positive outlook on Huntington Bancshares (HBAN), with 12-month price targets suggesting over 21% upside. Both Truist Financial and Morgan Stanley reiterated Buy ratings on the stock, though they revised EPS forecasts downwards for 2026 and 2027 due to reduced purchase accounting accretion from recent acquisitions. Despite these adjustments, the firms expect HBAN to meet its revenue goals, driven by core fee growth and synergies.
AMN Healthcare Services, Inc. Reports Q4 2025 Revenue of $748 Million with GAAP Loss of $0.20 per Share and Adjusted EPS of $0.22
AMN Healthcare reported Q4 2025 revenue of $748 million, a 2% year-over-year increase, alongside a GAAP net loss of $7.7 million and adjusted EPS of $0.22. While full-year 2025 revenue declined 8% to $2.73 billion, the company saw growth in travel nurse volume and significant debt reduction of $285 million for the year.
Truist Securities Adjusts Pediatrix Medical Price Target to $21 From $24, Maintains Hold Rating
Truist Securities has revised its price target for Pediatrix Medical Group (NYSE: MD) shares down to $21 from $24, while keeping a "Hold" rating on the stock. This adjustment follows the company's recent Q4 2025 earnings report. Pediatrix Medical Group is a provider of physician services specializing in newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care.
Wyndham Hotels Aims Higher With New Price Target and Expansion Moves
Wyndham Hotels & Resorts (WH) has seen its stock rise 7.0% following strategic expansions, including a deal to add nearly 2,000 rooms across four Choctaw Casino & Resorts properties. Truist increased its price target for WH to $99 from $98, maintaining a "Buy" rating due to revised revenue and expense models. The company reported a Q4 adjusted EPS of $0.93, exceeding projections, and exhibits strong operational effectiveness despite a slight dip in revenue.
Pediatrix Medical Group (NYSE:MD) Shares Gap Down After Earnings Miss
Pediatrix Medical Group (NYSE:MD) experienced a share price gap down after missing analyst earnings estimates for the quarter, reporting $0.50 EPS against an expected $0.53. Despite revenue slightly exceeding estimates at $493.77 million, it represented a 1.7% year-over-year decrease. The stock opened significantly lower at $18.84 from its previous close of $21.97, reflecting investor reaction to the disappointing earnings announcement.
Endeavour Capital Advisors Inc. Sells 35,857 Shares of East West Bancorp, Inc. $EWBC
Endeavour Capital Advisors Inc. has significantly reduced its stake in East West Bancorp, Inc. by selling 35,857 shares, cutting its holdings by 67.9%. Despite this, East West Bancorp reported strong Q3 earnings, beating analyst estimates, and increased its quarterly dividend. The article also notes recent insider selling activity, with approximately 120,585 shares sold by insiders over the last 90 days.
Truist Financial Corporation $TFC Shares Sold by Synovus Financial Corp
Synovus Financial Corp reduced its stake in Truist Financial Corporation by 6.7% in Q3, selling 28,416 shares but still holding 393,992 shares valued at $18,014,000. Truist's board approved a $10.0 billion share repurchase program and declared a quarterly dividend of $0.52. The company missed Q4 EPS estimates, with analysts maintaining a "Hold" rating and an average price target of $56.47, while insiders sold 21,660 shares totaling $1,075,087 over the past 90 days.
Levin Capital Strategies L.P. Takes $3.26 Million Position in Equitable Holdings, Inc. $EQH
Levin Capital Strategies L.P. initiated a new position in Equitable Holdings, Inc. (NYSE:EQH) during Q3, acquiring shares valued at approximately $3.26 million. Other institutional investors also adjusted their holdings in Equitable, and the stock currently has a "Moderate Buy" consensus rating from analysts with an average target price of $62.42. The company recently announced a quarterly dividend and a $1 billion share buyback plan, while insider transactions show both selling activity from executives.
Skandinaviska Enskilda Banken AB publ Lowers Holdings in Equitable Holdings, Inc. $EQH
Skandinaviska Enskilda Banken AB publ significantly reduced its stake in Equitable Holdings, Inc. (NYSE:EQH) by 49.2% in the third quarter, selling 161,402 shares and retaining 166,372 shares valued at approximately $8.45 million. Despite this, other institutional investors increased their positions in Equitable, which has an average analyst rating of "Moderate Buy" with a consensus price target of $62.42. Equitable also approved a $1.0 billion share repurchase plan and declared a quarterly dividend of $0.27 per share.
Vanguard Group Inc. Purchases 1,705,570 Shares of Brown & Brown, Inc. $BRO
Vanguard Group Inc. significantly increased its stake in Brown & Brown, Inc. (NYSE:BRO) by acquiring an additional 1,705,570 shares in the third quarter, bringing its total holding to 37,330,892 shares valued at approximately $3.50 billion. This investment now represents about 10.93% of Brown & Brown, with institutional investors collectively owning 71.01% of the company's stock. Brown & Brown recently reported quarterly earnings that slightly beat analyst expectations for EPS but had revenue that was modestly below consensus, with the firm maintaining a "Hold" rating from analysts with a consensus target price of $90.36.
Skandinaviska Enskilda Banken AB publ Boosts Position in Cytokinetics, Incorporated $CYTK
Skandinaviska Enskilda Banken AB publ significantly increased its stake in Cytokinetics, Incorporated, acquiring over 110,000 additional shares to hold a total of 149,957 shares valued at $8.24 million. This move is alongside other institutional investments and insider selling activity, with analysts maintaining a largely positive outlook for Cytokinetics, evidenced by multiple "Buy" ratings and upward revised price targets. Cytokinetics, a biopharmaceutical company, focuses on developing therapeutics for muscle function modulation, with its most advanced program targeting heart failure treatment.
A Look At Valley National Bancorp (VLY) Valuation After Recent Share Price Gains
Valley National Bancorp (VLY) has seen recent share price gains, with a 30-day return of 12.17% and a 90-day return of 26.62%, although its one-year return is higher at 38.37%. The stock is currently trading at $13.27, which is considered undervalued compared to a narrative-based fair value of $14.68, driven by expected deposit growth, margin improvements, and capital returns. The article suggests further investigation into the company's financial details and risks, particularly concerning commercial real estate exposure, despite the optimistic valuation.
Rhumbline Advisers Acquires 24,700 Shares of CAVA Group, Inc. $CAVA
Rhumbline Advisers increased its stake in CAVA Group, Inc. by 9.8%, acquiring an additional 24,700 shares to hold a total of 276,491 shares valued at approximately $16.7 million. Institutional investors now own about 73.15% of CAVA, which is rated as a "Moderate Buy" by analysts with an average price target of $82.21. Meanwhile, company insiders have recently been net sellers, offloading 42,843 shares worth $2.76 million in the last quarter, reducing their ownership to about 6.8%.
PagerDuty (PD): Truist Cites AI Narratives, Terminal Value Concerns as Key Drivers for Infrastructure Software
Truist has lowered its price target for PagerDuty (PD) from $16 to $12, citing concerns over terminal value in the infrastructure software sector and the increasing importance of AI narratives. The firm emphasized that vendors need to gain traction in AI use cases and move away from seat-based models. PagerDuty reported a 5% year-over-year revenue increase in Q3 2025, driven by new customer acquisitions and a strengthening product advantage in AI operations.
5 Revealing Analyst Questions From Sixth Street Specialty Lending’s Q4 Earnings Call
Sixth Street Specialty Lending (TSLX) reported Q4 earnings that beat Wall Street estimates for revenue, EPS, and operating income, despite a year-over-year revenue decline. The market reacted negatively due to pressures on loan spreads and increased competition. The article highlights key analyst questions and management's responses regarding portfolio strategy, the new SCP joint venture, investment pipeline, and credit spread outlook.
Truist Financial Raises Equity Lifestyle Properties (NYSE:ELS) Price Target to $69.00
Truist Financial has increased its price target for Equity Lifestyle Properties (NYSE:ELS) to $69.00 from $66.00, reiterating a "hold" rating, suggesting a 2.76% upside. Despite this, other analysts have varied ratings, ranging from "strong sell" to "overweight," resulting in a consensus "Moderate Buy" rating with an average target price of $70.42. Institutional investors hold a significant 97.21% of the company's stock, with major funds like Vanguard and Price T. Rowe increasing their positions.
Is Truist’s Mastercard-Powered Open Banking Move Reframing Its Digital Efficiency Story for Investors (TFC)?
Truist Financial Corporation (TFC) has integrated Mastercard's open finance technology to enable secure, API-based connections for clients to fintech apps, aiming to enhance digital efficiency and client growth. While this move supports Truist's digital strategy and client experience, it does not mitigate the immediate risk posed by its commercial real estate exposure. JPMorgan's increased price target for Truist reflects a positive outlook on loan and deposit growth, but investors should still consider the potential impact of real estate exposure.
Truist announces redemption of senior notes due March 2027
Truist Financial Corporation announced its plan to redeem all $1.25 billion of its fixed-to-floating rate senior notes due March 2, 2027, on March 2, 2026. The redemption will be at 100% of the principal amount plus accrued and unpaid interest, with interest ceasing on the redemption date. Truist is a leading financial services company headquartered in Charlotte, North Carolina, with $548 billion in assets as of December 31, 2025.
$1.25B Truist bond payout set as 2027 notes redeemed in 2026
Truist Financial (NYSE: TFC) announced it will redeem all outstanding fixed-to-floating senior notes due March 2, 2027, totaling $1.25 billion, on March 2, 2026. The redemption price will be 100% of the principal plus accrued and unpaid interest, with interest ceasing on the redemption date. This move is part of Truist's ongoing management of its funding profile and balance sheet, with total assets reported at $548 billion as of December 31, 2025.
Real estate students, professionals gather for UC/PNC Economic Outlook
The 32nd annual UC/PNC Economic Outlook event was held on February 13, bringing together over 350 attendees, including more than 70 real estate students, to discuss local, national, and international economic developments. Speakers Stuart Hoffman and Greg Valliere provided insights on economic forecasts and geopolitical impacts. The event was co-hosted by the UC Real Estate Center and PNC Bank, with thanks extended to their corporate partners.
Truist Financial Issues Positive Forecast for Alpine Income Property Trust (NYSE:PINE) Stock Price
Truist Financial has increased its price target for Alpine Income Property Trust (NYSE:PINE) to $21 from $18, maintaining a "hold" rating. This positive adjustment follows several other firms raising their ratings or price targets, contributing to a consensus "Moderate Buy" rating with an average target of $19.92. Despite a significant EPS miss in its latest quarterly results, the company surpassed revenue estimates and provided positive FY2026 guidance.
CenterBook Partners LP Has $15.92 Million Stake in CG Oncology, Inc. $CGON
CenterBook Partners LP significantly increased its stake in CG Oncology, Inc. (NASDAQ:CGON) by 52% in the third quarter, bringing its total holding to 395,340 shares valued at $15.92 million. This move positions CG Oncology as the firm's 24th largest holding, amidst broad bullish sentiment from Wall Street analysts who maintain a "Moderate Buy" consensus rating with an average price target of $68.58. The company's stock recently opened at $53.87, reflecting a market valuation of $4.35 billion, while also noting a director's recent share sale.
Truist Financial Forecasts Strong Price Appreciation for Digital Realty Trust (NYSE:DLR) Stock
Truist Financial has increased its price target for Digital Realty Trust (NYSE:DLR) stock to $202 from $200, maintaining a "buy" rating and indicating a potential 14% upside. This adjustment follows Digital Realty Trust's strong Q4 performance, which surpassed analyst expectations for both EPS and revenue, alongside optimistic FY2026 guidance. The stock currently holds a "Moderate Buy" consensus rating among analysts, with institutional investors owning nearly all shares.
Truist Financial Forecasts Strong Price Appreciation for Teva Pharmaceutical Industries (NYSE:TEVA) Stock
Truist Financial has increased its target price for Teva Pharmaceutical Industries (NYSE:TEVA) to $42 from $38, maintaining a "buy" rating and suggesting a potential upside of 22.54%. This forecast follows Teva's strong quarterly results, with EPS of $0.96 and revenue of $4.71 billion, both exceeding analyst estimates. However, there's a cautionary note regarding recent insider sales, with 422,060 shares sold in the last quarter, reducing insider ownership to 0.49%.
Truist Lowers PayPal (PYPL) Estimates Due to Slower Volume, Take Rate Compression
Truist has lowered its price target for PayPal (PYPL) to $39 from $58, maintaining a Sell rating, due to slower volume growth and take rate compression. This follows similar actions by RBC Capital and Susquehanna, with concerns raised about the pace of Branded Checkout's TPV growth and a material reduction in FY 2026 guidance. Analysts also highlighted disappointment in the slowdown of branded checkout growth in Q4 2025.
Truist Notes Operational Investments For Cytokinetics, Incorporated (CYTK) to Support Short-Term Growth
Truist has raised its price target for Cytokinetics, Incorporated (CYTK) to $92 from $84, maintaining a Buy rating. This adjustment reflects operational investments, including a drug's free supply program, the annual WAC price for Myqorzo, and anticipated increased operational costs in 2026 to support short-term growth. The company also announced the commercial availability of MYQORZO (aficamten) in the U.S. for treating obstructive hypertrophic cardiomyopathy (oHCM).
New financing aims to make buying Mercury boat engines easier
Sheffield Financial and Mercury Marine have partnered to simplify the purchase process for Mercury outboard engines and boat packages. This new retail financing program offers competitive rates, online prequalification, and seven-day-a-week access to specialized marine underwriting for faster credit decisions. The initiative aims to provide a consistent digital financing experience for both dealers and customers.
Robert Half Inc. $RHI Position Cut by Heartland Advisors Inc.
Heartland Advisors Inc. significantly reduced its stake in Robert Half Inc. (RHI) by 54.7% in Q3, selling 151,791 shares, though institutional ownership remains high at 92.41%. While AQR Capital Management notably increased its position, other large managers made adjustments. Analysts have a mixed view, with a "Reduce" consensus and a target price of $33.13, and concerns exist regarding the company's dividend payout ratio despite beating EPS estimates.
Analysts Offer Insights on Financial Companies: Kinsale Capital Group (KNSL), American International Group (AIG) and Sixth Street Specialty Lending (TSLX)
This article provides analyst ratings and price targets for three financial companies: Kinsale Capital Group (KNSL), American International Group (AIG), and Sixth Street Specialty Lending (TSLX). Truist Financial maintained a Buy rating on Kinsale Capital Group with a $450.00 price target, and a Moderate Buy consensus of $431.17 from analysts. Morgan Stanley issued a Hold rating on American International Group with an $83.00 price target, with a consensus Hold rating of $85.93. Truist Financial also maintained a Buy rating on Sixth Street Specialty Lending, setting a price target of $22.00, and a Moderate Buy consensus of $21.86.
Analysts’ Opinions Are Mixed on These Industrial Goods Stocks: Howmet Aerospace (HWM) and EquipmentShare.com, Inc. (EQPT)
This article summarizes analyst opinions on two industrial goods stocks: Howmet Aerospace (HWM) and EquipmentShare.com, Inc. (EQPT). UBS maintained a Hold rating on Howmet Aerospace with a $260.00 price target, while analysts overall have a Strong Buy consensus. Truist Financial initiated coverage on EquipmentShare.com with a Buy rating and a $43.00 price target, followed by Robert W. Baird with a Buy rating and a $63.00 price target, leading to a Moderate Buy consensus.
Principal Financial Group Inc. Buys 43,113 Shares of Heritage Insurance Holdings, Inc. $HRTG
Principal Financial Group Inc. increased its stake in Heritage Insurance Holdings, Inc. by 201.7% in Q3, acquiring 43,113 shares to own 64,490 shares valued at $1.62 million. Other institutional investors also significantly increased their positions, resulting in institutional ownership of 59.03%. While analysts rate HRTG a "Moderate Buy" with an average target price of $32.50, company insiders have sold approximately 48,333 shares in the last 90 days.
Analysts’ Opinions Are Mixed on These Industrial Goods Stocks: Howmet Aerospace (HWM) and EquipmentShare.com, Inc. (EQPT)
This article summarizes recent analyst ratings for Howmet Aerospace (HWM) and EquipmentShare.com, Inc. (EQPT), both industrial goods stocks. UBS maintained a Hold rating on Howmet Aerospace with a $260 price target, while Truist Financial initiated coverage on EquipmentShare.com, Inc. with a Buy rating and a $43 price target. Robert W. Baird also initiated coverage on EQPT with a Buy rating and a $63 price target, leading to a Moderate Buy consensus.
Envestnet Asset Management Inc. Purchases 176,581 Shares of Americold Realty Trust Inc. $COLD
Envestnet Asset Management Inc. increased its stake in Americold Realty Trust Inc. by 23.7%, purchasing an additional 176,581 shares to own a total of 921,709 shares valued at $11.28 million. The company has a consensus "Hold" rating from Wall Street analysts with an average price target of $13.85, although it currently has negative earnings and a negative payout ratio. Americold Realty Trust is a REIT specializing in temperature-controlled warehousing and logistics, offering comprehensive cold chain solutions.
Merit Financial Group LLC Grows Stock Holdings in Best Buy Co., Inc. $BBY
Merit Financial Group LLC significantly increased its stake in Best Buy Co., Inc. by 126.1% during the third quarter, now holding 30,212 shares valued at approximately $2.285 million. Despite mixed analyst ratings with an average "Hold" and a target price of $80.58, Best Buy reported strong Q3 earnings, beating estimates with $1.40 EPS, and set a positive FY2026 EPS guidance. The company also offers a substantial 5.8% dividend yield, though its payout ratio is high at 125.8%.
Truist Financial Corporation $TFC Position Lessened by Vanguard Group Inc.
Vanguard Group Inc. reduced its stake in Truist Financial Corporation by 1.2% in the third quarter, though it still holds over 119 million shares. Despite missing quarterly earnings estimates, Truist's board authorized a $10 billion share buyback and declared a $0.52 quarterly dividend. Insiders have recently sold shares, while analysts generally rate the stock as a "Hold" with an average price target of $56.47.
Truist Notes Operational Investments For Cytokinetics, Incorporated (CYTK) to Support Short-Term Growth
Truist has raised its price target for Cytokinetics (CYTK) to $92 from $84, maintaining a Buy rating, ahead of its Q4 results. This adjustment accounts for the impact of a free drug supply program, the annual WAC price for Myqorzo, and increased operational costs anticipated for 2026. Cytokinetics recently launched MYQORZO (aficamten) in the U.S. for treating obstructive hypertrophic cardiomyopathy (oHCM), marking its entry into the commercial biopharmaceutical stage.
Compass Pathways Launches Proposed $150.0 Million Public Offering
Compass Pathways plc announced a proposed public offering of $150.0 million in American Depositary Shares (ADSs) and pre-funded warrants. The biotechnology company, focused on mental health innovation, expects to grant underwriters an option to purchase an additional $22.5 million of ADSs. The offering is subject to market conditions, with Jefferies, TD Cowen, Cantor, and Stifel acting as joint book-runners.
Short Interest in Old National Bancorp (NASDAQ:ONB) Decreases By 13.8%
Old National Bancorp (NASDAQ:ONB) experienced a 13.8% decrease in short interest as of January 30th, totaling 17,433,745 shares. This represents 4.5% of the stock and a short-interest ratio of 5.1 days. Despite an insider selling a significant portion of their shares, institutional investors have increased their holdings, and analysts maintain a "Moderate Buy" rating with an average target price of $27.36.
BofA initiates Pitney Bowes stock with underperform rating By Investing.com
BofA Securities initiated coverage on Pitney Bowes Inc. (NYSE:PBI) with an underperform rating and a $9.00 price target, citing structural headwinds in its mailing businesses and risks to growth. Despite the company's efforts to streamline its portfolio and achieve cost savings, BofA believes leverage and risks to operating earnings will limit future shareholder returns. Other analysts, however, have initiated coverage with more optimistic ratings, noting CEO Kurt Wolf's turnaround progress and compelling valuation metrics.
Truist Financial Keeps Their Hold Rating on Advance Auto Parts (AAP)
Truist Financial has maintained a Hold rating on Advance Auto Parts (AAP) with a price target of $57.00, following a report from analyst Scot Ciccarelli. This rating comes despite the company reporting quarterly revenue of $1.97 billion and a net profit of $6 million in its latest earnings, compared to a net loss in the previous year. Other analysts have offered mixed ratings, with some reiterating a Sell while others have raised price targets.
